A Feasibility Trial of Esketamine Plus Cognitive Behavioral Therapy for Patients with Major Depressive Disorder Who are Hospitalized for Suicidal Ideation


Awarded By

Total Award Amount

  • 158188.00
  • Direct Costs

  • 106524.00
  • Sponsor Award Id

  • CON-80003894 (GR117937)
  • Contributor

  • Leah Pickett DNP, CRNP, PMHNPBC, DNP, CRNP, PMHNP-BC   Investigator  
  • Matthew Macaluso   Principal Investigator  
  • Michael Falola   Investigator  
  • Richard Shelton   Investigator  
  • Roberta May   Investigator  
  • Tiffany Nowell   Investigator